It has been shown that change in the methylation of HLA DPB1 (Major Histocompatibility Complex, class II, DP Beta 1) contributes to the development of multiple sclerosis, a disease of the central nervous system [17]. This evidence concerns the gene HLA-DPB1 and multiple sclerosis.